EPMA Journal is a journal of predictive, preventive and personalized medicine (PPPM). The journal provides expert viewpoints and research on medical innovations and advanced healthcare using predictive diagnostics, targeted preventive measures and personalized patient treatments. The journal is indexed by PubMed, Embase and Scopus.

  • The only journal in the field of predictive, preventive and personalized medicine (PPPM)
  • High visibility for your research
  • Official journal of the European Association for Predictive, Preventive & Personalised Medicine

Journal information

Editor-in-Chief
  • Olga Golubnitschaja
Publishing model
Hybrid (Transformative Journal). Learn about publishing Open Access with us

Journal metrics

4.901 (2019)
Impact factor
13 days
Submission to first decision
68 days
Submission to acceptance
171,227 (2020)
Downloads

Latest issue

Volume 12

Issue 1, March 2021

Predictive, Preventive and Personalised Medical Approach in Management of COVID-19 Pandemic, Sub-Optimal Health Conditions and Non-Communicable Diseases

Latest articles

Journal updates

  • COVID-19 and impact on peer review

    As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times.  Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

  • Featured article: Challenging management of severe chronic disorders in acute pandemic situation

    Chronic liver disease management is a comprehensive approach requiring multi-professional expertise and well-orchestrated healthcare measures thoroughly organized by responsible medical units. The corresponding multi-faceted chain of healthcare events is likely to be severely disturbed or even temporarily broken under the force majeure conditions such as global pandemics. Consequently, the chronic liver disease is highly representative for the management of any severe chronic disorder under lasting pandemics with unprecedented numbers of acutely diseased persons who, together with the chronically sick patient cohorts, have to be treated using the given capacity of healthcare systems with their limited resources.


    In this study, researchers explored the potential negative impact of the SARS CoV-2 outbreak on the quality of the advanced chronic liver disease (ACLD) management by considering two well-classified parameters: (1) the continuity of the patient registrations and (2) the level of mortality rates, comparing pre-COVID-19 statistics with these under the current pandemic in Slovak Republic.

    New Content Item
View all updates

About this journal

Electronic ISSN
1878-5085
Print ISSN
1878-5077
Abstracted and indexed in
  1. ANVUR
  2. CAB Abstracts
  3. CNKI
  4. Dimensions
  5. EBSCO Discovery Service
  6. EMBASE
  7. Gale
  8. Google Scholar
  9. Institute of Scientific and Technical Information of China
  10. Japanese Science and Technology Agency (JST)
  11. Journal Citation Reports/Science Edition
  12. Meta
  13. Naver
  14. Norwegian Register for Scientific Journals and Series
  15. OCLC WorldCat Discovery Service
  16. ProQuest Central
  17. ProQuest Health & Medical Collection
  18. ProQuest Health Research Premium Collection
  19. ProQuest-ExLibris Primo
  20. ProQuest-ExLibris Summon
  21. Psyndex
  22. PubMedCentral
  23. Reaxys
  24. SCImago
  25. SCOPUS
  26. Science Citation Index Expanded (SciSearch)
  27. TD Net Discovery Service
  28. UGC-CARE List (India)
Copyright information

Rights and permissions

Springer policies

© European Association for Predictive, Preventive and Personalised Medicine (EPMA)